In‐hospital arrhythmias in patients with acute myocardial infarction—the relation to the reperfusion strategy and their prognostic impact

References

• Lowel H., Dobson A., Keil U., Herman B., Hobbs M. S., Stewart A., et al. Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation 1993; 88: 2524–31
   PubMed Web of Science ®Google Scholar
• Antmann E. A., Braunwald E. Acute Myocardial Infarction. Heart Disease 6th Edition, E Braunwald, D Zipes, P Libby. W.B. Saunders Company, Philadelphia 2001; 1114–219
   Google Scholar
• Harris A. S. Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1950; 1: 1318–28
   PubMed Web of Science ®Google Scholar
• Kaplinsky E., Ogawa S., Balke C. W., Dreifus L. S. Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation 1979; 60: 397–403
   PubMedGoogle Scholar
• Bigger J. T., Jr., Dresdale F. J., Heissenbuttel R. H., Weld F. M., Wit A. L. Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 1977; 19: 255–300
   PubMed Web of Science ®Google Scholar
• El‐Sherif N., Scherlag B. J., Lazzara R., Hope R. R. Re‐entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone. Circulation 1977; 55: 686–702
   Google Scholar
• Opie L. H. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049–62
   PubMed Web of Science ®Google Scholar
• Krumholz H. M., Goldberger A. L. Reperfusion arrhythmias after thrombolysis. Electrophysiologic tempest, or much ado about nothing. Chest 1991; 99((Suppl))135S–40S
   Google Scholar
• Kaplinsky E., Ogawa S., Michelson E. L., Dreifus L. S. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms. Circulation 1981; 63: 333–40
   Google Scholar
• Sclarovsky S., Strasberg B., Fuchs J., Lewin R. F., Arditi A., Klainman E., et al. Multiform accelerated idioventricular rhythm in acute myocardial infarction: electrocardiographic characteristics and response to verapamil. Am J Cardiol 1983; 52: 43–7
   Google Scholar
• Olgin J. E., Zipes D. Specific Arrhythmias: Diagnosis and Treatment. Heart Disease 6th Edition, E Braunwald, D Zipes, P Libby. PE, W. B. Saunders, Philadelphia 2001; 866–7
   Google Scholar
• Bonnemeier H., Ortak J., Wiegand U. K., Eberhardt F., Bode F., Schunkert H., et al. Accelerated idioventricular rhythm in the post‐thrombolytic era: incidence, prognostic implications, and modulating mechanisms after direct percutaneous coronary intervention. Ann Noninvasive Electrocardiol 2005; 10: 179–87
   Google Scholar
• Penkoske P. A., Sobel B. E., Corr P. B. Disparate electrophysiological alterations accompanying dysrhythmia due to coronary occlusion and reperfusion in the cat. Circulation 1978; 58: 1023–35
   Google Scholar
• Goldberg S., Greenspon A. J., Urban P. L., Muza B., Berger B., Walinsky P., et al. Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J 1983; 105: 26–32
   Google Scholar
• Hohnloser S. H., Zabel M., Kasper W., Meinertz T., Just H. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991; 18: 44–9
   PubMedGoogle Scholar
• Gressin V., Louvard Y., Pezzano M., Lardoux H. Holter recording of ventricular arrhythmias during intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 1992; 69: 152–9
   Google Scholar
• Della Grazia P. M., Klugmann S., Morgera T., Salvi A., Pandullo C., Camerini F. Reperfusion ventricular arrhythmias during intracoronary thrombolysis. Eur Heart J 1986; 7((Suppl. A))23–30
   Google Scholar
• Miller F. C., Krucoff M. W., Satler L. F., Green C. E., Fletcher R. D., Del Negro A. A., et al. Ventricular arrhythmias during reperfusion. Am Heart J 1986; 112: 928–32
   Google Scholar
• Six A. J., Louwerenburg J. H., Kingma J. H., Robles de Medina E. O., van Hemel N. M. Predictive value of ventricular arrhythmias for patency of the infarct‐related coronary artery after thrombolytic therapy. Br Heart J 1991; 66: 143–6
   Google Scholar
• Gorgels A. P., Vos M. A., Letsch I. S., Verschuuren E. A., Bar F. W., Janssen J. H., et al. Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1988; 61: 231–5
   PubMedGoogle Scholar
• Chiladakis J. A., Vlachos N., Patsouras N., Mazarakis A., Manolis A. S. Usefulness of reperfusion ventricular arrhythmias in non‐invasive prediction of early reperfusion and sustained coronary artery patency in acute myocardial infarction. J Thromb 2001; 12: 231–6
   Google Scholar
• Califf R. M., O'Neil W., Stack R. S., Aronson L., Mark D. B., Mantell S., et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988; 108: 658–62
   Google Scholar
• Gore J. M., Ball S. P., Corrao J. M., Goldberg R. J. Arrhythmias in the assessment of coronary artery reperfusion following thrombolytic therapy. Chest 1988; 94: 727–30
   Google Scholar
• Vaturi M., Birnbaum Y. The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction. J Thromb 2000; 10: 137–47
   Google Scholar
• Doevendans P. A., Gorgels A. P., van der Zee R., Partouns J., Bar F. W., Wellens H. J. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1995; 75: 1206–10
   Google Scholar
• Ophuis A. J., Bar F. W., Vermeer F., Janssen W., Doevendans P. A., Haest R. J., et al. Angiographic assessment of prospectively determined non‐invasive reperfusion indices in acute myocardial infarction. Heart 2000; 84: 164–70
   Google Scholar
• Sutton A. G., Campbell P. G., Price D. J., Grech E. D., Hall J. A., Davies A., et al. Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method. Heart 2000; 84: 149–56
   Google Scholar
• Ilia R., Amit G., Cafri C., Gilutz H., Abu‐Ful A., Weinstein J. M., et al. Reperfusion arrhythmias during coronary angioplasty for acute myocardial infarction predict ST‐segment resolution. Coron Artery Dis 2003; 14: 439–41
   Google Scholar
• Manning A. S., Hearse D. J. Reperfusion‐induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 1984; 16: 497–518
   PubMed Web of Science ®Google Scholar
• Solomon S. D., Ridker P. M., Antman E. M. Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta‐analysis. Circulation 1993; 88: 2575–81
   Google Scholar
• Volpi A., Maggioni A., Franzosi M. G., Pampallona S., Mauri F., Tognoni G. In‐hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med 1987; 317: 257–61
   Google Scholar
• Boissel J. P., Castaigne A., Mercier C., Lion L., Leizorovicz A. Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience. European Myocardial Infarction Project. Eur Heart J 1996; 17: 213–21
   PubMed Web of Science ®Google Scholar
• Henkel D. M., Witt B. J., Gersh B. J., Jacobsen S. J., Weston S. A., Meverden R. A., et al. Ventricular arrhythmias after acute myocardial infarction: a 20‐year community study. Am Heart J 2006; 151: 806–12
   PubMedGoogle Scholar
• Brezins M., Elyassov S., Elimelech I., Roguin N. Comparison of patients with acute myocardial infarction with and without ventricular fibrillation. Am J Cardiol 1996; 78: 948–50
   Google Scholar
• Maggioni A. P., Zuanetti G., Franzosi M. G., Rovelli F., Santoro E., Staszewsky L., et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI‐2 results. Circulation 1993; 87: 312–22
   Google Scholar
• Newby K. H., Thompson T., Stebbins A., Topol E. J., Califf R. M., Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation 1998; 98: 2567–73
   PubMed Web of Science ®Google Scholar
• Ruiz‐Bailen M., Aguayo de Hoyos E., Ruiz‐Navarro S., Issa‐Khozouz Z., Reina‐Toral A., Diaz‐Castellanos M. A., et al. Ventricular fibrillation in acute myocardial infarction in Spanish patients: Results of the ARIAM database. Crit Care Med 2003; 31: 2144–51
   Google Scholar
• Josephson R. A., Papa L. A., Brooks M. M., Morris M., Akiyama T., Greene H. L. Effect of age on postmyocardial infarction ventricular arrhythmias (Holter Registry data from CAST I and CAST II). Cardiovascular Arrhythmia Suppression Trials. Am J Cardiol 1995; 76: 710–3
   Google Scholar
• Mont L., Cinca J., Blanch P., Blanco J., Figueras J., Brotons C., et al. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. J Am Coll Cardiol 1996; 28: 1670–6
   Google Scholar
• Volpi A., Cavalli A., Santoro L., Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction–results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI‐2) database. Am J Cardiol 1998; 82: 265–71
   PubMed Web of Science ®Google Scholar
• Volpi A., Cavalli A., Turato R., Barlera S., Santoro E., Negri E. Incidence and short‐term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI‐3) Data Base. Am Heart J 2001; 142: 87–92
   Google Scholar
• Mehta R. H., Harjai K. J., Grines L., Stone G. W., Boura J., Cox D., et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol 2004; 43: 1765–72
   PubMed Web of Science ®Google Scholar
• Henriques J. P., Gheeraert P. J., Ottervanger J. P., de Boer M. J., Dambrink J. H., Gosselink A. T., et al. Ventricular fibrillation in acute myocardial infarction before and during primary PCI. Int J Cardiol 2005; 105: 262–6
   PubMed Web of Science ®Google Scholar
• Vermeer F., Simoons M. C., Lubsen J. Reduced frequency of ventricular fibrillation after early thrombolysis in myocardial infarction. Lancet 1986; 1: 1147–8
   Google Scholar
• Opitz C. F., Finn P. V., Pfeffer M. A., Mitchell G. F., Pfeffer J. M. Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage. J Am Coll Cardiol 1998; 32: 261–7
   Google Scholar
• Arnold J. M., Antman E. M., Przyklenk K., Braunwald E., Sandor T., Vivaldi M. T., et al. Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. Am Heart J 1987; 113: 1055–65
   Google Scholar
• Kim C. B., Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 1993; 88: 2426–36
   PubMed Web of Science ®Google Scholar
• Kersschot I. E., Brugada P., Ramentol M., Zehender M., Waldecker B., Stevenson W. G., et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol 1986; 7: 1234–42
   PubMed Web of Science ®Google Scholar
• Sager P. T., Perlmutter R. A., Rosenfeld L. E., McPherson C. A., Wackers F. J., Batsford W. P. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 1988; 12: 19–24
   Google Scholar
• Berger P. B., Ruocco N. A., Ryan T. J., Frederick M. M., Podrid P. J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue‐type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. J Am Coll Cardiol 1993; 22: 1773–9
   Google Scholar
• Andersen H. R., Nielsen T. T., Rasmussen K., Thuesen L., Kelbaek H., Thayssen P., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733–42
   PubMed Web of Science ®Google Scholar
• Widimsky P., Groch L., Zelizko M., Aschermann M., Bednar F., Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823–31
   PubMed Web of Science ®Google Scholar
• Widimsky P., Budesinsky T., Vorac D., Groch L., Zelizko M., Aschermann M., et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE‐2. Eur Heart J 2003; 24: 94–104
   PubMed Web of Science ®Google Scholar
• Grines C. L., Browne K. F., Marco J., Rothbaum D., Stone G. W., O'Keefe J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673–9
   PubMed Web of Science ®Google Scholar
• Grines C. L., Westerhausen D. R., Jr., Grines L. L., Hanlon J. T., Logemann T. L., Niemela M., et al. A randomized trial of transfer for primary angioplasty versus on‐site thrombolysis in patients with high‐risk myocardial infarction: The Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002; 39: 1713–9
   PubMed Web of Science ®Google Scholar
• Larosa C., Infusino F., Sgueglia G. A., Aurigemma C., Sestito A., Lombardo A., et al. Effect of primary percutaneous coronary intervention versus thrombolysis on ventricular arrhythmias and heart rate variability in acute myocardial infarction. Ital Heart J 2005; 6: 629–33
   Google Scholar
• Hod H., Gotlieb S., Green M., Hammerman H., Zahger D., Hasdai D., et al. (Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade). Harefuah 2006; 145: 326–31; 400
   Google Scholar
• Keeley E. C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20
   PubMed Web of Science ®Google Scholar
• Zijlstra F., de Boer M. J., Hoorntje J. C., Reiffers S., Reiber J. H., Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680–4
   PubMed Web of Science ®Google Scholar
• Gheeraert P. J., Henriques J. P., De Buyzere M. L., Voet J., Calle P., Taeymans Y., et al. Out‐of‐hospital ventricular fibrillation in patients with acute myocardial infarction: coronary angiographic determinants. J Am Coll Cardiol 2000; 35: 144–50
   PubMed Web of Science ®Google Scholar
• Schwartz P. J., Stone H. L. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation 1980; 62: 1256–65
   PubMed Web of Science ®Google Scholar
• Al‐Khatib S. M., Stebbins A. L., Califf R. M., Lee K. L., Granger C. B., White H. D., et al. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO‐III trial. Am Heart J 2003; 145: 515–21
   PubMed Web of Science ®Google Scholar
• Al‐Khatib S. M., Granger C. B., Huang Y., Lee K. L., Califf R. M., Simoons M. L., et al. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST‐segment elevation: incidence, predictors, and outcomes. Circulation 2002; 106: 309–12
   Google Scholar
• Widdershoven J. W., Gorgels A. P., Vermeer F., Dijkman L. W., Verstraaten G. M., Dassen W. R., et al. Changing characteristics and in‐hospital outcome in patients admitted with acute myocardial infarction. Observations from 1982 to 1994. Eur Heart J 1997; 18: 1073–80
   Google Scholar
• Khairy P., Thibault B., Talajic M., Dubuc M., Roy D., Guerra P. G., et al. Prognostic significance of ventricular arrhythmias post‐myocardial infarction. Can J Cardiol 2003; 19: 1393–404
   PubMed Web of Science ®Google Scholar
• Volpi A., Cavalli A., Franzosi M. G., Maggioni A., Mauri F., Santoro E., et al. One‐year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. Am J Cardiol 1989; 63: 1174–8
   PubMed Web of Science ®Google Scholar
• Koster R. W., Dunning A. J. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 1985; 313: 1105–10
   PubMedGoogle Scholar
• MacMahon S., Collins R., Peto R., Koster R. W., Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 1988; 260: 1910–6
   PubMed Web of Science ®Google Scholar
• Van de Werf F., Ardissino D., Betriu A., Cokkinos D. V., Falk E., Fox K. A., et al. Management of acute myocardial infarction in patients presenting with ST‐segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24: 28–66
   PubMed Web of Science ®Google Scholar
• Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group., Am J Cardiol. 56. 35G–8G
   Google Scholar
• Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo‐controlled international trial. The MIAMI Trial Research Group., Eur Heart J. 6. 199–226
   Google Scholar
• Mechanisms for the early mortality reduction produced by beta‐blockade started early in acute myocardial infarction: ISIS‐1. ISIS‐1 (First International Study of Infarct Survival) Collaborative Group. Lancet 1988; 1: 921–3
   Google Scholar
• Harjai K. J., Stone G. W., Boura J., Grines L., Garcia E., Brodie B., et al. Effects of prior beta‐blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2003; 91: 655–60
   Google Scholar
• Heidbuchel H., Tack J., Vanneste L., Ballet A., Ector H., Van de Werf F. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta‐blocker or a bradycardiac agent on their incidence. Circulation 1994; 89: 1051–9
   Google Scholar
• Chen Z. M., Pan H. C., Chen Y. P., Peto R., Collins R., Jiang L. X., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo‐controlled trial. Lancet 2005; 366: 1622–32
   PubMed Web of Science ®Google Scholar
• McMurray J., Kober L., Robertson M., Dargie H., Colucci W., Lopez‐Sendon J., et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: Results of the Carvedilol Post‐Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 2005; 45: 525–30
   PubMed Web of Science ®Google Scholar
• Harada K., Komuro I., Hayashi D., Sugaya T., Murakami K., Yazaki Y. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation 1998; 97: 315–7
   PubMed Web of Science ®Google Scholar
• Ozer M. K., Sahna E., Birincioglu M., Acet A. Effects of captopril and losartan on myocardial ischemia‐reperfusion induced arrhythmias and necrosis in rats. Pharmacol Res 2002; 45: 257–63
   Google Scholar
• Zhu B., Sun Y., Sievers R. E., Browne A. E., Pulukurthy S., Sudhir K., et al. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia‐reperfusion. J Am Coll Cardiol 2000; 35: 787–95
   PubMed Web of Science ®Google Scholar
• Bonnemeier H., Schafer U., Ortak J., Kurz T., Katus H. A., Richardt G., et al. Low doses of intracoronary enalaprilat suppress reperfusion‐associated ventricular arrhythmias after primary percutaneous coronary interventions for acute myocardial infarction. Pacing Clin Electrophysiol 2007; 30((Suppl. 1))S160–5
   Google Scholar
• GISSI‐3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6‐week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 1994; 343: 1115–22
   Google Scholar
• ISIS‐4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS‐4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995; 345: 669–85
   Google Scholar
• Sogaard P., Gotzsche C. O., Ravkilde J., Norgaard A., Thygesen K. Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril. Circulation 1994; 90: 101–7
   Google Scholar
• Ohman E. M., George B. S., White C. J., Kern M. J., Gurbel P. A., Freedman R. J., et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation 1994; 90: 792–9
   PubMedGoogle Scholar
• Kono T., Morita H., Nishina T., Fujita M., Onaka H., Hirota Y., et al. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol 1996; 28: 876–81
   Google Scholar
• Stone G. W., Marsalese D., Brodie B. R., Griffin J. J., Donohue B., Costantini C., et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI‐II) Trial Investigators. J Am Coll Cardiol 1997; 29: 1459–67
   PubMedGoogle Scholar
• Brodie B. R., Stuckey T. D., Hansen C., Muncy D. Intra‐aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high‐risk patients with acute myocardial infarction. Am J Cardiol 1999; 84: 18–23
   Google Scholar
• Sanborn T. A., Sleeper L. A., Bates E. R., Jacobs A. K., Boland J., French J. K., et al. Impact of thrombolysis, intra‐aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol 2000; 36((Suppl A))1123–9
   Google Scholar
• Kurland G. S., Pressman D. The incidence of arrhythmias in acute myocardial infarction studies with a constant monitoring system. Circulation 1965; 31: 834–41
   Google Scholar
• Wong C. K., White H. D., Wilcox R. G., Criger D. A., Califf R. M., Topol E. J., et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO‐III experience. Am Heart J 2000; 140: 878–85
   PubMed Web of Science ®Google Scholar
• Crenshaw B. S., Ward S. R., Granger C. B., Stebbins A. L., Topol E. J., Califf R. M. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO‐I experience. global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 1997; 30: 406–13
   PubMed Web of Science ®Google Scholar
• Trappolini M., Scorza A., Chillotti F. M., Trappolini F., Danese A., De Vito F., et al. Prognostic significance of atrial fibrillation in thrombolysed and non thrombolysed patients. Minerva Cardioangiol 2006; 54: 471–9
   Google Scholar
• Goldberg R. J., Yarzebski J., Lessard D., Wu J., Gore J. M. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community‐wide perspective. Am Heart J 2002; 143: 519–27
   PubMed Web of Science ®Google Scholar
• Rathore S. S., Berger A. K., Weinfurt K. P., Schulman K. A., Oetgen W. J., Gersh B. J., et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000; 101: 969–74
   PubMed Web of Science ®Google Scholar
• Labinaz M., Mathias J., Pieper K., Granger C. B., Lincoff A. M., Moliterno D. J., et al. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. Eur Heart J 2005; 26: 128–36
   Google Scholar
• Kinjo K., Sato H., Ohnishi Y., Hishida E., Nakatani D., Mizuno H., et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92: 1150–4
   PubMed Web of Science ®Google Scholar
• Asanin M., Vasiljevic Z., Matic M., Vujisic‐Tesic B., Arandjelovic A., Marinkovic J., et al. Outcome of patients in relation to duration of new‐onset atrial fibrillation following acute myocardial infarction. Cardiology 2006; 107: 197–202
   Google Scholar
• Kober L., Swedberg K., McMurray J. J., Pfeffer M. A., Velazquez E. J., Diaz R., et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 2006; 8: 591–8
   PubMed Web of Science ®Google Scholar
• Pedersen O. D., Bagger H., Kober L., Torp‐Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376–80
   PubMed Web of Science ®Google Scholar
• Ehrlich J. R., Hohnloser S. H., Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27: 512–8
   PubMed Web of Science ®Google Scholar
• Antman E. M., Anbe D. T., Armstrong P. W., Bates E. R., Green L. A., Hand M., et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671–719
   PubMedGoogle Scholar
• Harjai K. J., Boura J., Grines L., Goldstein J., Stone G. W., Brodie B., et al. Comparison of effectiveness of primary angioplasty for proximal versus distal right coronary artery culprit lesion during acute myocardial infarction. Am J Cardiol 2002; 90: 1193–7
   PubMed Web of Science ®Google Scholar
• McDonald K., O'Sullivan J. J., Conroy R. M., Robinson K., Mulcahy R. Heart block as a predictor of in‐hospital death in both acute inferior and acute anterior myocardial infarction. Q J Med 1990; 74: 277–82
   Google Scholar
• Berger P. B., Ruocco N. A., Jr., Ryan T. J., Frederick M. M., Jacobs A. K., Faxon D. P. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol 1992; 20: 533–40
   Google Scholar
• Nicod P., Gilpin E., Dittrich H., Polikar R., Henning H., Ross J., Jr. Long‐term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol 1988; 12: 589–94
   PubMedGoogle Scholar